Publications

Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor

Devillier R, Calmels B, Guia S, Taha M, Fauriat C, Mfarrej B, Venton G, Vivier E, Olive D, Chabannon C, Blaise D, Ugolini S. Cancers (Basel) , 2021 , 13, PMID: 34071607

Campylobacter infection promotes IFN gamma-dependent intestinal pathology via ILC3 to ILC1 conversion

Wayne T Muraoka, Anna A Korchagina, Qingqing Xia, Sergey A Shein, Xi Jing, Zhao Lai, Korri S Weldon, Li-Ju Wang, Yidong Chen, Lawrence W Kummer, Markus Mohrs, Eric Vivier, Ekaterina P Koroleva, Alexei V Tumanov Mucosal Immunol, 2021 , 14, 703-716

Involvement of the complement cascade in severe forms of COVID-19

Chouaki Benmansour N, Carvelli J, Vivier É. M S-MEDECINE SCIENCES, 2021 , 37, 333-341, PMID: 33835019

Liver type 1 innate lymphoid cells develop locally via an interferon-γ-dependent loop

Bai L, Vienne M, Tang L, Kerdiles Y, Etiennot M, Escalière B, Galluso J, Wei H, Sun R, Vivier E, Peng H, Tian Z. Science, 2021 , PMID: 33766856

Natural killers or ILC1s? That is the question.

Seillet C, Brossay L, Vivier E. Current Opinion In Immunology, 2020 , 68, 48-53, PMID: 33069142

Harnessing innate immunity in cancer therapy

Demaria O., Cornen S., Daëron M., Morel Y., Medzhitov R., Vivier E. Nature, 2019 , 574, , 45–56, PMID: 31578484

Neuroendocrine regulation of innate lymphoid cells

Quatrini L, Vivier E, Ugolini S. Immunol Rev., 2018 , 286(1):120-136., PMID: 30294960

Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD1 expression on NK cells

Quatrini L, Wieduwild E, Escaliere B, Filtjens J, Chasson L, Laprie C, Vivier E, Ugolini S. Nature Immunology, 2018 , 19, 954-+, PMID: 30127438